Skip to content

Search

Showing results for "aboriginal respiratory"

Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis

Jonathan Rosemary Carapetis AM Wyber AM MBBS FRACP FAFPHM PhD FAHMS MBChB MPH FRACGP PhD Executive Director; Co-Head, Strep A Translation; Co-Founder

Skin Care Assessment in Broome and Port Hedland (SCAB Heal) project

Skin disease has several serious complications including heart and kidney disease.

Strong Skin App

Designed by community for community, the Strong Skin App is a go-to resource to support your skin health.

Flu Program for Patients

Flu season is here. The Paediatric Influenza Vaccine Program has started at PCH. Available now  to inpatients and children attending outpatient appointments, everyone is encouraged to get the influenza vaccination.ne. 

About

Learn more about the Wesfarmers Centre of Vaccines and Infectious Diseases

Travel Scholarships

Thank you to our Sponsors Contact us If you'd like to get in touch, please contact Marie Nadal-Sims by phone or email. Phone: (08) 6319 1001 Email:

Funding

The Centre is committed to supporting high quality research by providing support for researchers to undertake activities of high priority to the WCVID.

ORIGINS Co-Director nominated in the 2024 Western Australian of the Year Awards

ORIGINS Co-Director nominated in the 2024 Western Australian of the Year Awards

The Association Between Obesity and COVID-19 Severity in Children Differed Between SARS-CoV-2 Variants: A Multicountry Hospital-based Observational Study

Obesity was a risk factor for severe COVID-19 in children during early outbreaks of ancestral SARS-CoV-2 and the Delta variant. However, the relationship between obesity and COVID-19 severity during the Omicron wave remains unclear.

Walking the walk to include pregnant participants in non-obstetric clinical trials: Insights from the SNAP Trial

Despite several calls for greater inclusion of pregnant people in non-obstetric clinical trials, their systematic exclusion remains common practice. Excluding pregnant individuals from clinical trials may result in unintended consequences such as inadequate treatment of medical conditions in pregnancy, inappropriate dosing of medications, and investigational therapies being used off-label outside of the context of a clinical trial, risking adverse events in the absence of demonstrated efficacy.